AstraZeneca profits soar on cancer drugs, Alexion buy

Revenue soared almost one fifth to $44.4 billion, thanks to a strong contribution from oncology or cancer treatments that offset sliding fourth-quarter sales of its Covid vaccine.

published on : 9th February 2023

Pharmaceutical giant AstraZeneca's profits fall, Covid vaccine sales dip further 

The pharmaceutical group added that sales of its Covid-19 vaccine Vaxzevria slumped 49 per cent in the second quarter.

published on : 29th July 2022

AstraZeneca claims positive medicine trial for 'severe' Covid

AstraZeneca's statement says that the phase-three trial was carried out mostly on participants 'at high risk of progression to severe Covid-19'.

published on : 8th June 2022

AstraZeneca, SASTRA ink pact for research

On the collaboration with SASTRA, Siva Padmanabhan, the Managing Director of AZIPL, said,

published on : 1st June 2022

AstraZeneca India to plant 5000 trees in Bengaluru's open jail area as part of global campaign

All the 5000 trees being planted under this programme in Bengaluru will have smart geo-tags enabling individualistic tracking of each remotely

published on : 7th March 2022

If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

published on : 24th August 2020